The content on this site is intended for healthcare professionals only
Rare cancers and the difficulties in making clinical decisions
Published: 27 Sep 2014
Views: 2317
Dr Paolo Casali - National Tumour Institute, Milan, Italy
At a press conference at ESMO 2014, Dr Casali addresses the challenges of taking clinical decisions in rare cancers.
Related Videos
Pembrolizumab with chemoradiation therapy vs placebo plus CRT for locally advanc...
Prof Jean-Pascal Machiels - Cliniques Universitaires Sain-Luc, Brussels, Belgium
11 Sep 2022
Locally and advanced immunotherapy developments and new agents in lung cancer
Dr George Simon - Moffitt Advent Health Clinical Research Unit, Tampa, USA
9 Jul 2022
CheckMate 9ER: aRCC patients on nivolumab plus cabozantinib achieved deeper resp...
Dr Cristina Suarez - Vall d’Hebron University Hospital, Catalonia, Spain
6 Jun 2022
Ibrutinib improves PFS by 50% for older patients with newly diagnosed mantle cel...
Dr Michael Wang - MD Anderson Cancer Center, Houston, USA
4 Jun 2022
AORTIC 2021: Goals of AORTIC
Dr Verna Vanderpuye - AORTIC 2021 Programme Director, Ghana
21 Oct 2021
Long term outcome of enfortumab vedotin + pembrolizumab in first line locally ad...
Dr Terence Friedlander - UCSF, San Francisco, USA
4 Jun 2021
Latest in EGFR-positive NSCLC with exon 20 insertion mutations
Prof Sanjay Popat, Prof Michael Thomas, Dr Marina Garassino, Dr Rosario Campelo,...
9 Feb 2021
Why overall survival is still the gold standard end point
Dr Bishal Gyawali - Queen's University, Kingston, Canada
13 Jan 2021
What is global oncology and what is the presence of global oncology in Europe
Prof Cristina Stefan - Institute of Oncology 'Prof Dr Alexandru Trestioreanu', B...
12 Oct 2020